Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    23519529 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
Condition: Age Related Maculopathy
Interventions: Dietary Supplement: Lutein/ Zeaxanthin + Omega-3-FA;   Dietary Supplement: Placebo
2 Not yet recruiting Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
Condition: Changes in Macular Pigment Optical Density
Interventions: Dietary Supplement: S1: Dosage-dependency;   Other: S2: Kale extract versus kale purée;   Other: S3: Kale extract: AMD-patients

Indicates status has not been verified in more than two years